Drug Metabolism Letters (ERA Journal)

Drug Metabolism Letters is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Drug Metabolism Letters issn is: 1872-3128.

The fields covered by Drug Metabolism Letters as part of the evaluation of Australian university research excellence are:

Medical Biochemistry and Metabolomics Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Medical Biochemistry and Metabolomics field include:

- Anti-Cancer Drugs: international journal on anti-cancer agents
- BioData Mining
- Biochemical and Biophysical Research Communications
- Biomarker Insights
- Cellular and Molecular Biology
- Chimica Oggi
- Cold Spring Harbor Perspectives in Medicine
- International Journal on Disability and Human Development
- Journal of Clinical Hypertension
- Journal of Receptor Ligand and Channel Research
- Journal of Venom Research
- Nutrition and Dietary Supplements
- Prostaglandins and Other Lipid Mediators
- Redox Biology
- The Federation of European Biochemical Societies (FEBS) Journal

ERA Research Rankings Submenu

- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List

Latest News and Updates:

- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page